{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T19:37:58Z","timestamp":1774640278340,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.urolonc.2022.04.019","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T17:09:53Z","timestamp":1654016993000},"page":"383.e1-383.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Identification of potential biomarkers and novel therapeutic targets through genomic analysis of small cell bladder carcinoma and associated clinical outcomes"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4293-4680","authenticated-orcid":false,"given":"Earle F.","family":"Burgess","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Alexa","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad","family":"Livasy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Symanowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoran","family":"Gatalica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nury M.","family":"Steuerwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Arguello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cory R.","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Michael","family":"Korn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claud M.","family":"Grigg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin T.","family":"Matulay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter E.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth I.","family":"Heath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Raghavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2022.04.019_bib0001","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.euf.2017.09.001","article-title":"Treatment patterns and survival outcomes for patients with small cell carcinoma of the bladder","volume":"4","author":"Fischer-Valuck","year":"2018","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0002","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.euo.2019.12.002","article-title":"Urothelial cancers with small cell variant histology have confirmed high tumor mutational burden, frequent TP53 and RB mutations, and a unique gene expression profile","volume":"4","author":"Hoffman-Censits","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0003","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1002\/cncr.26197","article-title":"A surveillance, epidemiology, and end results analysis of small cell carcinoma of the bladder: epidemiology, prognostic variables, and treatment trends","volume":"117","author":"Koay","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0004","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/JU.0000000000001305","article-title":"A systematic review and meta-analysis of variant histology in urothelial carcinoma of the bladder treated with radical cystectomy","volume":"204","author":"Mori","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0005","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1053\/j.seminoncol.2012.08.009","article-title":"Small cell bladder cancer: biology and management","volume":"39","author":"Fahed","year":"2012","journal-title":"Semin Oncol"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0006","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3233\/BLC-190259","article-title":"Limited stage small cell bladder cancer: outcomes of a contemporary cohort","volume":"6","author":"Grigg","year":"2020","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0007","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/S0002-9440(10)62369-3","article-title":"Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma","volume":"166","author":"Cheng","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0008","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.euf.2017.03.007","article-title":"Small-cell carcinomas of the urinary bladder and prostate: TERT promoter mutation status differentiates sites of malignancy and provides evidence of common clonality between small-cell carcinoma of the urinary bladder and urothelial carcinoma","volume":"4","author":"Priemer","year":"2018","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0009","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/ijc.2910410115","article-title":"Establishment and characterization of a new human bladder cancer cell line showing features of squamous and glandular differentiation","volume":"41","author":"Russell","year":"1988","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0010","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1158\/1078-0432.CCR-17-2655","article-title":"Small-cell carcinomas of the bladder and lung are characterized by a convergent but distinct pathogenesis","volume":"24","author":"Chang","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0011","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1038\/s41388-018-0192-5","article-title":"Comprehensive genomic profiling of neuroendocrine bladder cancer pinpoints molecular origin and potential therapeutics","volume":"37","author":"Shen","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0012","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature14664","article-title":"Comprehensive genomic profiles of small cell lung cancer","volume":"524","author":"George","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0013","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/annonc\/mdw005","article-title":"Clinical correlation of extensive-stage small-cell lung cancer genomics","volume":"27","author":"Dowlati","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0014","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/ajcp\/77.2.123","article-title":"The World Health Organization histological typing of lung tumours","volume":"77","year":"1982","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0015","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1378\/chest.12-2377","article-title":"Executive summary: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Detterbeck","year":"2013","journal-title":"Chest."},{"key":"10.1016\/j.urolonc.2022.04.019_bib0016","unstructured":"https:\/\/www.carismolecularintelligence.com\/wp-content\/uploads\/2020\/04\/592-Gene-List.pdf."},{"key":"10.1016\/j.urolonc.2022.04.019_bib0017","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0018","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.12688\/f1000research.15931.1","article-title":"FastQ Screen: A tool for multi-genome mapping and quality control","volume":"7","author":"Wingett","year":"2018","journal-title":"F1000Res."},{"key":"10.1016\/j.urolonc.2022.04.019_bib0019","unstructured":"Li H. Aligning Sequence Reads, Clone Sequences and Assembly Contigs with BWA-MEM. arXiv:13033997. 2013."},{"key":"10.1016\/j.urolonc.2022.04.019_bib0020","unstructured":"Van der Auwera G, O'Connor B. Genomics in the Cloud: Using Docker, GATK, and WDL in Terra. O'Reilly Media. 2020."},{"key":"10.1016\/j.urolonc.2022.04.019_bib0021","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0022","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","article-title":"The ensembl variant effect predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0023","doi-asserted-by":"crossref","unstructured":"Islam S, Wu Y, D\u00edaz-Gay M, Bergstrom E, He Y, Barnes M, et al. Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor. bioRxiv. 2021.","DOI":"10.1016\/j.xgen.2022.100179"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004873","article-title":"Genome-wide copy number detection and visualization from targeted DNA sequencing","volume":"12","author":"Talevich","year":"2016","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0025","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive molecular characterization of muscle-invasive bladder cancer","volume":"171","author":"Robertson","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0026","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1158\/1078-0432.CCR-18-1001","article-title":"ERCC2 helicase domain mutations confer nucleotide excision repair deficiency and drive cisplatin sensitivity in muscle-invasive bladder cancer","volume":"25","author":"Li","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0027","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1001\/jamaoncol.2016.1056","article-title":"Clinical validation of chemotherapy response biomarker ERCC2 in muscle-invasive urothelial bladder carcinoma","volume":"2","author":"Liu","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0028","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1158\/1078-0432.CCR-16-1040","article-title":"PARP inhibitor activity correlates with SLFN11 expression and demonstrates synergy with temozolomide in small cell lung cancer","volume":"23","author":"Lok","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0029","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1001\/jamaoncol.2019.2963","article-title":"Evaluation of POLE and POLD1 mutations as biomarkers for immunotherapy outcomes across multiple cancer types","volume":"5","author":"Wang","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0030","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nature08822","article-title":"The landscape of somatic copy-number alteration across human cancers","volume":"463","author":"Beroukhim","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0031","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.eururo.2014.06.050","article-title":"Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder","volume":"67","author":"Kim","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0032","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1186\/s12885-021-08078-y","article-title":"RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer","volume":"21","author":"Manzano","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0033","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1056\/NEJMoa1817323","article-title":"Erdafitinib in locally advanced or metastatic urothelial carcinoma","volume":"381","author":"Loriot","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0034","doi-asserted-by":"crossref","first-page":"e521","DOI":"10.1016\/j.clgc.2016.12.012","article-title":"Response to pembrolizumab in a patient with chemotherapy refractory bladder cancer with small cell variant histology: a case report and review of the literature","volume":"15","author":"Wilde","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0035","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1158\/2159-8290.CD-14-0623","article-title":"Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma","volume":"4","author":"Van Allen","year":"2014","journal-title":"Cancer Discov"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0036","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrm3822","article-title":"Understanding nucleotide excision repair and its roles in cancer and ageing","volume":"15","author":"Marteijn","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0037","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.cell.2012.06.039","article-title":"TRIP12 and UBR5 suppress spreading of chromatin ubiquitylation at damaged chromosomes","volume":"150","author":"Gudjonsson","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0038","doi-asserted-by":"crossref","first-page":"11268","DOI":"10.1093\/nar\/gkz824","article-title":"UBR5 interacts with the replication fork and protects DNA replication from DNA polymerase eta toxicity","volume":"47","author":"Cipolla","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0039","doi-asserted-by":"crossref","first-page":"11243","DOI":"10.1073\/pnas.1610735113","article-title":"BMI1-UBR5 axis regulates transcriptional repression at damaged chromatin","volume":"113","author":"Sanchez","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0040","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1182\/bloodadvances.2019000702","article-title":"Multiple myeloma with 1q21 amplification is highly sensitive to MCL-1 targeting","volume":"3","author":"Slomp","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0041","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/leu.2012.367","article-title":"MCL1 is deregulated in subgroups of diffuse large B-cell lymphoma","volume":"27","author":"Wenzel","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0042","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1002\/cam4.774","article-title":"Copy-number variation of MCL1 predicts overall survival of non-small-cell lung cancer in a Southern Chinese population","volume":"5","author":"Yin","year":"2016","journal-title":"Cancer Med"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0043","doi-asserted-by":"crossref","first-page":"7734","DOI":"10.1093\/nar\/gkz634","article-title":"DAXX in cancer: phenomena, processes, mechanisms and regulation","volume":"47","author":"Mahmud","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0044","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1128\/MCB.23.20.7108-7121.2003","article-title":"Daxx silencing sensitizes cells to multiple apoptotic pathways","volume":"23","author":"Chen","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0045","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1101\/sqb.2007.72.004","article-title":"The role of circadian regulation in cancer","volume":"72","author":"Gery","year":"2007","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"10.1016\/j.urolonc.2022.04.019_bib0046","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.molcel.2006.03.038","article-title":"The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells","volume":"22","author":"Gery","year":"2006","journal-title":"Mol Cell"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143922001478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143922001478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:24:55Z","timestamp":1761042295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143922001478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S1078143922001478"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2022.04.019","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of potential biomarkers and novel therapeutic targets through genomic analysis of small cell bladder carcinoma and associated clinical outcomes","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2022.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}